Holding Co Cato serves as Executive at VistaGen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Holding Co Cato has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2011 involved exercising options for 424,124 shares valued at $0.
Holding Co Cato currently holds 3,310,836 shares of VistaGen Therapeutics, Inc. (VSTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holding Co Cato has been a net neutral trader of VSTA stock. They have purchased $0 and sold $0 worth of shares.
Holding Co Cato's most recent insider trade was on Dec 15, 2011, when they sold 424,124 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |